(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 13.78% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.71%.
Irhythm Technologies's revenue in 2024 is $537,091,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2024 to be $18,305,558,157, with the lowest IRTC revenue forecast at $18,264,045,413, and the highest IRTC revenue forecast at $18,342,104,365. On average, 5 Wall Street analysts forecast IRTC's revenue for 2025 to be $21,581,847,592, with the lowest IRTC revenue forecast at $21,486,671,271, and the highest IRTC revenue forecast at $21,672,525,917.
In 2026, IRTC is forecast to generate $25,310,841,461 in revenue, with the lowest revenue forecast at $24,919,203,553 and the highest revenue forecast at $25,620,921,978.